BioSpace News Archive

Innovative immuno-therapy company welcomes proven leaders in pharma and therapeutics

Company’s glass package for retinal implants paves way for further medical advances.

FDA’s highest priorities is advancing policies that increase competition as a way to help make drugs more affordable and improve access.

Lonza is hosting a free 60-minute webinar on the CRISPR/Cas9 genome editing method.

Protalex, Inc. (OTCQB: PRTX), a clinical-stage biopharmaceutical company, today announced that preliminary results from its European Phase 1b open-label, dose-escalation study of PRTX-100 in adult patients with persistent/chronic immune thrombocytopenia (ITP) (PRTX-100-203 Study) will be presented at the upcoming European Hematology Association (EHA) 23rd Annual Meeting being held in Stockholm from June 14-17, 2018

U.S. Food and Drug Administration sent official requests for information to four e-cigarette manufacturers.

Aegea Biotechnologies obtains multiple US and International issued patents related to next generation nucleic acid technology including whole genome amplification, the specific capture of desired nucleic acid fragments, and methods for the highly sensitive detection of genetic alterations of interest, including biomarkers associated with cancer.

Favorable safety and tolerability profile consistent with Phase 1a data SYNT001 treatment resulted in clinical improvement as measured by Pemphigus Disease Area Index (PDAI) score, with clinical effect persisting beyond the treatment period Rapid reductions in total IgG and circulating immune complex (CIC) levels

- AGEN1884 (CTLA-4) and AGEN2034 (PD-1) show objective clinical responses - More than 100 patients treated with AGEN1884 and AGEN2034 - Combination trial has commenced in cervical cancer

Lustgarten Foundation Distinguished Scholar Douglas Fearon, M.D., a professor at Cold Spring Harbor Laboratory (CSHL), has discovered how pancreatic cancer metastasizes to the liver following surgery, as reported in today’s online edition of leading biomedical journal Science.